left ventricular assist device (LVAD)
Jump to navigation
Jump to search
Introduction
Mechanical left ventricular assist device.
Indications
- NYHA class 4 heart failure
- prior to cardiac transplantation
- recovery from cardiogenic shock
- LVAD is primary therapy*
- in connection with combination drug therapy#
* case of placing LVAD in 73 yo woman with BP of 161/112 mm Hg, HR of 144/min, LVEF of 20%, moderate mitral regurgitation[15]
* cardiac transplantation relatively contraindicated in patients > 72 years of agw
Contraindications
Procedure
- continuous flow device superior to pulsatile flow device[3]
- intrapericardial centrifugal flow device non inferior to axial flow device[9]
- centrifugal-flow device superior to an axial-flow device[11]
Complications
- infection
- bleeding
- device malfunction
- stroke
- device thrombosis[5]
- magnetically levitated centrifugal-flow HeartMate 3 significantly reduced rates of thrombotic pump malfunction[8]
- ventricular thrombus
- acquired von-Willebrand's disease (vWD)[4]
* 52% 1 year survival vs 25% with medical management
# combination drug therapy
- start lisinopril, losartan, spironolactone, carvedilol
- monitor for hyperkalemia
- after achieving maximal regression of LV dilatation, add clenbuterol & replace carvedilol with bisoprolol
Management
- anticoagulation with warfarin to prevent ventricular thrombus[6]
More general terms
Additional terms
- cardiac transplantation; heart transplant
- heart failure (HF)
- New York Heart Association classification of heart failure
References
- ↑ Journal Watch 21(24):197, 2001 Rose EA et al for the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. NEJM 345:1435, 2001 PMID: https://www.ncbi.nlm.nih.gov/pubmed/11794191
- ↑ Birks EJ et al Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 2006 355:1873
Renlund DG & Kfoury AG When the failing, end-stage heart is not end-stage. N Engl J Med 2006, 355:1922 - ↑ Jump up to: 3.0 3.1 Slaughter MS et al. for the HeartMate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009 Dec 3;361(23):2241-51. Epub 2009 Nov 17. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19920051 <Internet> http://dx.doi.org/10.1056/NEJMoa0909938
Fang JC. Rise of the machines - Left ventricular assist devices as permanent therapy for advanced heart failure. N Engl J Med 2009 Nov 17 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/19920052 <Internet> http://dx.doi.org/10.1056/NEJMe0910394 - ↑ Jump up to: 4.0 4.1 Medical Knowledge Self Assessment Program (MKSAP) 15, 16, 17, 18. American College of Physicians, Philadelphia 2009, 2012, 2015, 2018.
- ↑ Jump up to: 5.0 5.1 Starling RC et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med 2014 Jan 2; 370:33 PMID: https://www.ncbi.nlm.nih.gov/pubmed/24283197
- ↑ Jump up to: 6.0 6.1 Brock AS et al A Not-So-Obscure Cause of Gastrointestinal Bleeding N Engl J Med 2015; 372:556-561. February 5, 2015 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/25651250 <Internet> http://www.nejm.org/doi/full/10.1056/NEJMcps1302223
- ↑ Garbade J, Barten MJ, Bittner HB, Mohr FW. Heart transplantation and left ventricular assist device therapy: two comparable options in end-stage heart failure? Clin Cardiol. 2013 Jul;36(7):378-82 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23595910
- ↑ Jump up to: 8.0 8.1 Mehra MR et al. A fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med 2016 Nov 16 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/27959709 <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1610426
- ↑ Jump up to: 9.0 9.1 Rogers JG et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med 2017 Feb 2; 376:451. <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28146651 Free Article <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1602954
Hetzer R, Delmo Walter EM. Mechanical circulatory support devices - in progress. N Engl J Med 2017 Feb 2; 376:487 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/28146667 <Internet> http://www.nejm.org/doi/10.1056/NEJMe1613755 - ↑ Jump up to: 10.0 10.1 Bansal N, Hailpern SM, Katz R et al. Outcomes associated with left ventricular assist devices among recipients with and without end-stage renal disease. JAMA Intern Med 2017 Dec 18; PMID: https://www.ncbi.nlm.nih.gov/pubmed/29255896
Thomas SS et al. The Renal Challenge With Left Ventricular Assist Device Therapy-When Enough Is Enough. JAMA Intern Med. 2017 Dec 18. PMID: https://www.ncbi.nlm.nih.gov/pubmed/29255894 - ↑ Jump up to: 11.0 11.1 Mehra MR, Goldstein DJ, Uriel N et al. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 2018; 378:1386-1395. April 12, 2018. ePub Mar 11 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/29526139 <Internet> http://www.nejm.org/doi/10.1056/NEJMoa1800866
- ↑ Robertson J, Long B, Koyfman A. The emergency management of ventricular assist devices. Am J Emerg Med. 2016 Jul;34(7):1294-301. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/27162114
- ↑ Stokes MB, Bergin P, McGiffin D. Role of long-term mechanical circulatory support in patients with advanced heart failure. Intern Med J. 2016 May;46(5):530-40. Review. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26010730
- ↑ Stokes MB, Saxena P, Mariani JA et al Left Ventricular Assist Device (LVAD) as a Bridge to Recovery for Tachycardia-Mediated Cardiomyopathy. J Card Surg. 2015 Nov;30(11):871-3. dEpub 2015 Sep 8. PMID: https://www.ncbi.nlm.nih.gov/pubmed/26350745
- ↑ Jump up to: 15.0 15.1 Geriatric Review Syllabus, 10th edition (GRS10) Harper GM, Lyons WL, Potter JF (eds) American Geriatrics Society, 2019
Geriatric Review Syllabus, 12th edition (GRS12) Colburn JL, Wescott AM, Potter JF (eds) American Geriatrics Society, 2025 - ↑ Hamad EA, Byku M, Larson SB, Billia F. LVAD therapy as a catalyst to heart failure remission and myocardial recovery. Clin Cardiol. 2023 Oct;46(10):1154-1162. PMID: https://www.ncbi.nlm.nih.gov/pubmed/37526373 PMCID: PMC10577530 Free PMC article. Review. https://pmc.ncbi.nlm.nih.gov/articles/PMC10577530/
- ↑ Kanwar MK, McIlvennan CK, Lohmueller LC et al Defining Optimal Outcomes in Patients with Left Ventricular Assist Devices. ASAIO J. 2021 Apr 1;67(4):397-404. PMID: https://www.ncbi.nlm.nih.gov/pubmed/32701625